{
    "code": "52026550",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026550",
    "time": "2016-06-17 04:51:08",
    "許可證字號": "衛部藥輸字第026550號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/09\/23",
    "發證日期": "104\/09\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202655001",
    "中文品名": "敏立紓凝膠",
    "英文品名": "Mirvaso 3mg\/g Gel(Brimonidine)",
    "適應症": "適用於成人病患，作為酒糟鼻臉部紅斑的症狀治療。",
    "劑型": "393外用凝膠劑",
    "包裝": "一千公克以下塑膠軟管裝 2g、10g及30g塑膠軟管裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "BRIMONIDINE TARTRATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0941001100  香港商高德美有限公司台灣分公司",
    "申請商地址": "台北市大同區承德路一段17號9樓之4、17號9樓之5、17號9樓之6",
    "主製造廠": {
        "製造廠名稱": "F150143100  LABORATOIRES GALDERMA.",
        "製造廠廠址": "ZONE INDUSTRIELLE-MONTDESIR 74540 ALBY SUR CHERAN FRANCE",
        "製造廠公司地址": "TOUR EUROPLAZA-LA DEFENSE 4,20 AVENUE ANDRE PROTHIN 92927 LA DEFENSE CEDEX FRANCE",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005310",
            "成分名稱": "BRIMONIDINE TARTRATE",
            "含量描述": "(equivalent to Brimonidine tartrate......5MG)",
            "含量": "3.3000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "MIRVASO Chinese leaflet_Mar.1_2016-105-04-06.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026550&Seq=002&Type=9"
        },
        {
            "title": "敏立紓凝膠_Oct 15_2015-104-10-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026550&Seq=001&Type=9"
        },
        {
            "title": "外盒標籤-105-04-06.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026550&Seq=001&Type=8"
        }
    ]
}